Who starts treatment: engagement in the NIDA collaborative cocaine treatment study.
This study addressed the role of demographic variables, severity of drug dependence, and drug-related problems infacilitating or impeding engagement into a research treatment. Patients were tracked through various stages of entry for the research treatment: phone screening, intake, and randomization to treatment. Results suggested that certain demographic factors put patients more at risk for dropping out at intake and randomization. African-American and unemployed patients were less likely to stay in treatment at both stages, with largest differences at intake. Younger patients were less likely to complete both phases, with bigger differences noted at randomiZation. Patients with more days of cocaine use andpatients referred from advertisements were less likely to keep their intake appointments.
Siqueland
Lynne
L
University of Pennsylvania Medical School, Philadelphia 19104, USA. siqueland@pobox.com
Crits-Christoph
Paul
P
Gallop
Bob
B
Gastfriend
David
D
Lis
Judy
J
Frank
Arlene
A
Griffin
Margaret
M
Blaine
Jack
J
Luborsky
Lester
L
D000328:Adult; D019970:Cocaine-Related Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D009316:National Institutes of Health (U.S.); D010342:Patient Acceptance of Health Care; D010352:Patient Dropouts; D016320:Substance Abuse Treatment Centers; D014481:United States / Q000453:epidemiology